Task: Answer the multiple-choice question.
Query: Which drug exhibits a 4.270\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a Cn1c(SCC(=O)N/N=C/c2ccncc2)nc2ccccc21
b COc1ccc(Br)cc1/C=N/NC(=O)C[n+]1ccccc1.[Cl-]
c O=C(NCCN1CCN(C(=O)c2cc3ccccc3oc2=O)CC1)c1cc2ccccc2oc1=O
Answer: a. Cn1c(SCC(=O)N/N=C/c2ccncc2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(SCC(=O)N/N=C/c2ccncc2)nc2ccccc21
Cn1c(SCC(=O)N/N=C/c2ccncc2)nc2ccccc21
2-(1-methylbenzimidazol-2-yl)sulfanyl-N-[(E)-pyridin-4-ylmethylideneamino]acetamide